Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision metadata has been updated from Revision: v3.5.0 to Revision: v3.5.3, alongside an updated date entry (2026-04-13). This reflects a publication/version refresh of the study record rather than a modification to the trial details or outcomes.
    Difference
    0.2%
    Check dated 2026-04-24T06:00:03.000Z thumbnail image
  2. Check
    19 days ago
    Change Detected
    Summary
    New study record updates dated 2026-04-08 and 2026-04-09 were added, and entries for 2026-04-01 and 2026-04-02 were removed.
    Difference
    0.1%
    Check dated 2026-04-09T21:36:31.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    Two additions were recorded on 2026-04-01 and 2026-04-02, and two deletions were recorded on 2026-03-24 and 2026-03-25, updating the study record.
    Difference
    0.1%
    Check dated 2026-04-02T15:28:49.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Administrative updates were made to the study record on 2026-03-24 and 2026-03-25, with deletions on 2026-03-17 and 2026-03-18.
    Difference
    0.1%
    Check dated 2026-03-26T11:27:41.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Additions on 2026-03-18 and 2026-03-17 include Revision: v3.5.0. Deletions on 2026-03-11 and 2026-03-10 include Revision: v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T05:57:11.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision notes indicate an update to v3.4.3 on 2026-03-10 and 2026-03-11, replacing the previous v3.4.2.
    Difference
    0.2%
    Check dated 2026-03-12T00:00:43.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.